Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Beneficiary Profile: Orygen

June 9, 2020
1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.
Read Transcript

One in five young people will have experienced a depressive episode by the time they are 18. That’s why, we at Orygen believe in treating early and focusing on recovery.

Established in 2002, Orygen is widely regarded as one of the world’s leading research organisations focusing on mental ill-health in young people, led by former Australian of the Year, Professor Patrick McGorry AO. Orygen’s vision and advocacy led to the national success of headspace.

Orygen's research is world-leading, impactful and creates real change. Working directly with young people, their families and friends, they pioneer new, positive approaches to the prevention and treatment of mental disorders. Orgyen make sure that policy makers understand the need and cost of mental ill-health.

Professor McGorry says "the team at Cooper Investors have been an incredible advocate for Orygen and importantly, youth mental health. The funding we receive from Hearts & Minds Investments Limited give us the critical flexibility of being able to support innovative projects, that may otherwise not receive funding.

With thanks to Cooper Investors and Hearts & Minds Investments Limited, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework, through a partnership with the World Economic Forum".

The collaboration is part of the Forum’s Platform on Shaping the Future of Health and Healthcare. This has enabled Orygen to maximise the engagement of the Forum’s strategic partners and elevate the profile of their world leading youth mental health organisation among key private and public stakeholders globally, with the work promoted at events during the United Nations General Assembly 2019 and Davos 2020.

Professor McGorry said “youth mental health is a global issue that brings with it a massive emotional, physical and economic toll that affects young people, their families and communities all over the world.”

The Orygen/World Economic Forum youth mental health project has involved widespread consultation with clinical academics, service providers, policy makers and young people from over 20 different countries in different resource and cultural settings. The project has produced:

  • A Global Framework for Youth Mental Health Care to support communities, regions and countries around the world to develop and deliver effective youth mental health services and supports.
  • An investment framework to support funders access the economic evidence for early intervention and prevention.
  • An advocacy toolkit to support young people, families and their local communities to make youth mental health a priority for leaders, funders and policy makers.

The Framework was launched by the Premier of Victoria on 27 May 2020. The virtual event included a panel discussion involving young people from Australia, Philippines, Canada, South Africa and Brazil. It attracted over 1000 registered participants from 92 countries. The next stages of the project will include working with a number of communities around the world to support implementation of the Youth Mental Health Framework in their own countries.

“Ultimately, we want to see all young people the world over being able to access the mental health care in their local communities that they need to ensure they lead long and fulfilling lives,” Professor McGorry said.

As part of our impact video series, we spoke with Professor McGorry, discussing the importance of medical research, his recent breakthroughs and the vital need for private funding. You can watch the video below:

You can learn more about Orygen at their website here.

One in five young people will have experienced a depressive episode by the time they are 18. That’s why, we at Orygen believe in treating early and focusing on recovery.

Established in 2002, Orygen is widely regarded as one of the world’s leading research organisations focusing on mental ill-health in young people, led by former Australian of the Year, Professor Patrick McGorry AO. Orygen’s vision and advocacy led to the national success of headspace.

Orygen's research is world-leading, impactful and creates real change. Working directly with young people, their families and friends, they pioneer new, positive approaches to the prevention and treatment of mental disorders. Orgyen make sure that policy makers understand the need and cost of mental ill-health.

Professor McGorry says "the team at Cooper Investors have been an incredible advocate for Orygen and importantly, youth mental health. The funding we receive from Hearts & Minds Investments Limited give us the critical flexibility of being able to support innovative projects, that may otherwise not receive funding.

With thanks to Cooper Investors and Hearts & Minds Investments Limited, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework, through a partnership with the World Economic Forum".

The collaboration is part of the Forum’s Platform on Shaping the Future of Health and Healthcare. This has enabled Orygen to maximise the engagement of the Forum’s strategic partners and elevate the profile of their world leading youth mental health organisation among key private and public stakeholders globally, with the work promoted at events during the United Nations General Assembly 2019 and Davos 2020.

Professor McGorry said “youth mental health is a global issue that brings with it a massive emotional, physical and economic toll that affects young people, their families and communities all over the world.”

The Orygen/World Economic Forum youth mental health project has involved widespread consultation with clinical academics, service providers, policy makers and young people from over 20 different countries in different resource and cultural settings. The project has produced:

  • A Global Framework for Youth Mental Health Care to support communities, regions and countries around the world to develop and deliver effective youth mental health services and supports.
  • An investment framework to support funders access the economic evidence for early intervention and prevention.
  • An advocacy toolkit to support young people, families and their local communities to make youth mental health a priority for leaders, funders and policy makers.

The Framework was launched by the Premier of Victoria on 27 May 2020. The virtual event included a panel discussion involving young people from Australia, Philippines, Canada, South Africa and Brazil. It attracted over 1000 registered participants from 92 countries. The next stages of the project will include working with a number of communities around the world to support implementation of the Youth Mental Health Framework in their own countries.

“Ultimately, we want to see all young people the world over being able to access the mental health care in their local communities that they need to ensure they lead long and fulfilling lives,” Professor McGorry said.

As part of our impact video series, we spoke with Professor McGorry, discussing the importance of medical research, his recent breakthroughs and the vital need for private funding. You can watch the video below:

You can learn more about Orygen at their website here.

Disclaimer: This material has been prepared by Orygen, published on June 9, 2020. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
July 1, 2026

Improving care for adults with motor neuron diseases

Building better care for adults living with Motor Neuron Disease and Spinal Muscular Atrophy.

Read More
July 1, 2026

Understanding fatigue in young people with Charcot-Marie-Tooth disease

Developing a tool to improve understanding, research and care.

Read More
Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).Pictured left to right: Professor Gina Ravenscroft (Perkins), Jasmine Chew, Sam Payne (CEO and Founder, Pink Elephants Support Network), and Shelby Mullin (Perkins).
July 1, 2026

Giving families living with rare diseases the answers they need

Supporting research to improve the diagnosis of rare genetic neuromuscular diseases and build the foundations for future treatments.

Read More
Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher Picture: Dr Laura Grice, Lead Researcher
July 1, 2026

Understanding spinal cord injury recovery

The world's first molecular map of spinal cord injury across time and injury levels

Read More
Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium Picture: Professor Lindy Jeffree, Neurosurgeon and Chair, Brain Cancer Australia National Consortium
July 1, 2026

Building the foundations for faster progress against brain cancer

Uniting researchers, clinicians and patients to accelerate research and improve patient care.

Read More
July 1, 2026

Accelerating CAR-T cell therapies for patients in need 

Bringing innovative cancer therapies closer to patients.

Read More
July 1, 2026

Supporting babies at high risk of cerebral palsy from the very beginning

Testing a family-centred early intervention program to improve outcomes for infants and support parents during the first critical months of life.

Read More
July 1, 2026

Making early cerebral palsy screening more accessible

Exploring new ways to identify babies at risk of cerebral palsy sooner and support better outcomes.

Read More
Picture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHIPicture: Professor Tracy Putoczki, Laboratory Head at WEHI
July 1, 2026

Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.

Read More
Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI Picture: Professor Jane Visvader and Professor Geoff Lindeman from the Breast Cancer Laboratory at WEHI
July 1, 2026

Understanding how breast cancer begins

Tracking the earliest changes in BRCA mutation carriers to help prevent cancer before it starts.

Read More
July 1, 2026

A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

Read More
Picture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthurPicture: Professor Daniel MacArthur
July 1, 2026

Closing the gap in rare disease diagnosis for Australian families

Building better genomic tools and more representative data to help families receive answers sooner.

Read More
PICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her teamPICTURE: A/Prof Rebecca Nisbet and her team
July 1, 2026

Developing a new mRNA vaccine for Alzheimer’s disease

Using innovative technology to explore new possibilities for treatment and prevention.

Read More
Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS. Researchers are growing human “mini-brains” in the laboratory and introducing immune cells from people living with MS.
July 1, 2026

Unlocking new approaches for Multiple Sclerosis

Understanding why the brain fails to repair itself and exploring new treatment possibilities.

Read More
July 1, 2026

Helping emergency doctors make faster decisions with AI

Using Australian-developed artificial intelligence to improve emergency care.

Read More